Designed for both men and women, Myomin is clinically proven to reduce the size and symptoms of myoma. In addition, those with osteoporosis, kidney, and liver problems have found this dietary supplement to be safe and effective. It also balances excess hormone levels and normalizes hormonal systems, boosts formation of interferon interlukin-2 and tumor necrosis factor, regulates and alleviates discomfort, inhibits aromatase, blocks estrogen.
Myomin has three functions:
- It inhibits the aromatase enzyme, effectively reducing estradiol levels by preventing the conversion of androgens to estrone and estradiol. This allows testosterone and estriol (the good estrogen) to accumulate. Aromatase inhibition has become a worthwhile target in many estrogen-dominant disorders
- It competes with estradiol at the estrogen receptors. This function is particularly effective in cases where estrogen receptors are fully stimulated (e.g. after HRT). Competing with estradiol prevents estradiol from binding to receptors. As a result, proliferation of cells is avoided and abnormal growth inhibited.
- In increase interferon (IFN) and interleukin-2 (IL-2). IL-2 induces the proliferation of immune cells, enhancing the body's ability to kill tumor cells. IFN stimulates natural killer cells and is active against tumors.
It is worth noting that, in the Chang Hai Hospital studies show that approximately 1% of the subjects taking Myomin experienced side effects such as nausea and bloating. These symptoms abate when Myomin dosage is reduced or when it is taken with meals.
Myomin reduces estradiol levels
One study performed at the Shanghai Medical School illustrates the effect of Myomin on estradiol levels of mice during pregnancy – a period when estradiol levels are especially high. Two groups of 12 mice each were used in the study. One group was used as the control. The other group was given Myomin beginning 15 days into pregnancy. Three days later (on the 18 th day of the study), the average estradiol level of the Myomin group was 7.22pg/ml, approximately seven tiems less than the control group. After 6 days of taking Myomin (on the 21 st day of the study), their average estradiol level was 8.81 pg/ml while it was 85.98 pg/ml for the control group.
In another study, 90 female mice were divided into three groups. Each group was then given Myomin for 30, 60 and 180 days, respectively. The average estradiol levels after each period was 50.6, 36.6, and 32.4 pg/ml, respectively. After 180 days, the estradiol level stabilised. These results demonstrate long-term use of Myomin reduces estradiol in such a way that it maintains around the normal level. No side effects were reporet in this study.
A human study involved 60 postmenopausal women with cysts and/or fibroids. Postmenopausal women were studied because their estradiol levels are more stable than those of premenopaual women. Initially, the average estradiol level was 74.52 pg/ml. After only 10 days on Myomin, their average estradiol level reduced to 38.84 pg/ml. The fibroids, cysts and associated pain gradually reduced.
Capsules per Container: 2 Capsules, 1000 mg.
Ingredients: Astragalus membranaceus, Curcuma zedoaria, Cyperus rotundus
Serving Size: Two (2) Vegetarian Capsules
Daily Value not established for these ingredients. Contains no preservatives, no sodium, no artificial colors, no yeast, no animal products. All natural. Keep out of reach of children.
Suggested Use: As a dietary supplement, take 2 to 3 capsules per use, 2 to 3 times a day after meals, or as directed by your health care practitioner.
* This statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.